Canaccord Genuity Cuts Stryker Price Target to $300 From $385
Canaccord Genuity cut its price target on Stryker to $300 per share from $385 and downgraded the stock to Hold from Buy.
Canaccord Genuity cut its price target on Stryker to $300 per share from $385 and downgraded the stock to Hold from Buy.